9.75
price down icon0.31%   -0.03
after-market Dopo l'orario di chiusura: 9.75
loading
Precedente Chiudi:
$9.78
Aprire:
$9.72
Volume 24 ore:
57,296
Relative Volume:
0.52
Capitalizzazione di mercato:
$140.58M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-1.9231
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
-2.60%
1M Prestazione:
+3.72%
6M Prestazione:
-32.90%
1 anno Prestazione:
-43.02%
Intervallo 1D:
Value
$9.72
$9.93
Intervallo di 1 settimana:
Value
$9.585
$10.17
Portata 52W:
Value
$7.8701
$18.37

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
Nome
Anika Therapeutics Inc
Name
Telefono
(781) 457-9000
Name
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Name
Dipendente
288
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
ANIK's Discussions on Twitter

Confronta ANIK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.75 141.01M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-17 Iniziato B. Riley Securities Buy
2024-11-01 Reiterato Barrington Research Outperform
2023-08-14 Aggiornamento Barrington Research Mkt Perform → Outperform
2023-03-07 Downgrade Barrington Research Outperform → Mkt Perform
2022-11-09 Aggiornamento Barrington Research Mkt Perform → Outperform
2022-10-14 Ripresa Stephens Equal-Weight
2022-03-09 Downgrade Barrington Research Outperform → Mkt Perform
2022-03-09 Downgrade Stephens Overweight → Equal-Weight
2021-11-16 Iniziato Stephens Overweight
2021-07-16 Iniziato UBS Neutral
2020-12-16 Aggiornamento Barrington Research Mkt Perform → Outperform
2020-05-08 Downgrade Barrington Research Outperform → Mkt Perform
2020-01-21 Aggiornamento Sidoti Neutral → Buy
2020-01-10 Aggiornamento First Analysis Sec Outperform → Strong Buy
2019-11-05 Iniziato BWS Financial Sell
2019-09-24 Reiterato Barrington Research Outperform
2019-09-23 Downgrade First Analysis Sec Strong Buy → Outperform
2019-07-25 Aggiornamento First Analysis Sec Neutral → Strong Buy
2019-02-22 Downgrade First Analysis Sec Outperform → Neutral
2019-02-22 Downgrade Sidoti Buy → Neutral
2018-07-27 Aggiornamento Barrington Research Mkt Perform → Outperform
2018-06-20 Downgrade Barrington Research Outperform → Mkt Perform
2018-06-20 Downgrade First Analysis Sec Overweight → Equal-Weight
2018-05-04 Aggiornamento Barrington Research Mkt Perform → Outperform
2018-02-23 Downgrade Barrington Research Outperform → Mkt Perform
2018-01-24 Aggiornamento First Analysis Sec Equal-Weight → Overweight
2017-10-27 Reiterato Barrington Research Outperform
2016-05-09 Aggiornamento Singular Research BUY - Long-Term → Buy
2016-04-27 Downgrade Northland Capital Outperform → Market Perform
2016-02-26 Reiterato Barrington Research Outperform
Mostra tutto

Anika Therapeutics Inc Borsa (ANIK) Ultime notizie

pulisher
12:34 PM

Anika Therapeutics (NASDAQ:ANIK) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

12:34 PM
pulisher
07:06 AM

What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 EndofYear Setup & Technical Pattern Based Signals - newser.com

07:06 AM
pulisher
06:32 AM

What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockTrade Ideas & Scalable Portfolio Growth Methods - newser.com

06:32 AM
pulisher
06:02 AM

Key metrics from Anika Therapeutics Inc.’s quarterly data2025 Winners & Losers & Verified Technical Signals - newser.com

06:02 AM
pulisher
05:28 AM

Is Anika Therapeutics Inc. stock supported by strong cash flows2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

05:28 AM
pulisher
04:41 AM

Why Anika Therapeutics Inc. stock could rally in 2025Weekly Profit Analysis & Breakout Confirmation Alerts - newser.com

04:41 AM
pulisher
02:57 AM

Does Anika Therapeutics Inc. show high probability of reboundJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com

02:57 AM
pulisher
01:39 AM

Why Anika Therapeutics Inc. stock could outperform in 2025Bear Alert & Low Risk High Win Rate Stock Picks - newser.com

01:39 AM
pulisher
01:31 AM

Detecting support and resistance levels for Anika Therapeutics Inc.Inflation Watch & Long Hold Capital Preservation Plans - newser.com

01:31 AM
pulisher
Oct 30, 2025

Is Anika Therapeutics Inc. stock positioned for long term growthTrade Ideas & Risk Managed Investment Entry Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Strategies to average down on Anika Therapeutics Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

How to escape a deep drawdown in Anika Therapeutics Inc.2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Using AI based signals to follow Anika Therapeutics Inc.Quarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Anika Therapeutics Inc. stock sustain revenue growth2025 Momentum Check & Real-Time Price Movement Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Will Anika Therapeutics Inc. (AKP) stock benefit from sector leadershipMarket Performance Report & Daily Technical Forecast Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can Anika Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Fast Gain Swing Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is Anika Therapeutics Inc. stock attractive for growth ETFsWeekly Gains Summary & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer? - TipRanks

Oct 27, 2025

Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Anika Therapeutics Inc Azioni (ANIK) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):